Literature DB >> 34838222

Assessing the evidence on remdesivir.

Marius Trøseid1, Maya Hites2, Andreas Barratt-Due3, Florence Ader4, Yazdan Yazdanpanah5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34838222     DOI： 10.1016/S1473-3099(21)00695-2

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN： 1473-3099            Impact factor:   25.071


× No keyword cloud information.
  2 in total

Review 1.  Pandemic COVID-19, an update of current status and new therapeutic strategies.

Authors:  Antonio Vitiello; Raffaele La Porta; Ugo Trama; Francesco Ferrara; Andrea Zovi; Amogh Milind Auti; Marina Di Domenico; Mariarosaria Boccellino
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2022-07-02       Impact factor: 3.195

Review 2.  Carbohydrate-based drugs launched during 2000-2021.

Authors:  Xin Cao; Xiaojing Du; Heng Jiao; Quanlin An; Ruoxue Chen; Pengfei Fang; Jing Wang; Biao Yu
Journal:  Acta Pharm Sin B       Date:  2022-05-23       Impact factor: 14.903
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.